Clinical trial · Observational
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
PaCaReg: A Multicenter Registry Trial for the Assessement of Clinical, Epidemiological and Biological Profiles in Patients With Pancreatic Ductal Adenocarcinoma
NCT04099134CI-TRIAL-00040838PaCaRegrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Adenocarcinoma | Pancreatic Adenocarcinoma | ALIAS | 0.90 |
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- General assessment of applied therapy modalities in pancreatic cancer
- timeFrame
- First diagnose to death or end of surveillance (5 years after curative resection)
- measure
- Quality of life in pancreatic cancer patients
- timeFrame
- First diagnose to death or end of surveillance (5 years after curative resection)
- description
- EORTC QLQ c30 and PAN 26
Secondary outcomes (3)
- measure
- General epidemiologic assessment
- timeFrame
- First diagnose to death or end of surveillance (5 years after curative resection)
- description
- Epidemiologic questionaire
- measure
- Assessment of tumor surveillance in pancreatic cancer patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection) * Age =\>18 years * written informed consent Exclusion Criteria: * papillary cancer * neuroendocrine pancreatic tumors
References
Publications (0)
Data not yet available
No reference posted for this study.